Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-31

Clinical Trial Update: Bupivacaine Verus Pethidine for Post Cesarean Section Pain Relief [Phase 2, Phase 3]

View source ↗

Summary

Clinical trials comparing bupivacaine versus pethidine for post-cesarean section pain relief have completed phases 2 and 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • pethidine (meperidine)

Snippet

Sponsor: Ain Shams University | Conditions: Obstetric Pain | Phase 2, Phase 3 | Status: COMPLETED